EOS Imaging: Filing of the First-Half 2016 Financial Report

Mittwoch, 21.09.2016 17:50



PARIS --(BUSINESS WIRE)--

Regulatory News:

EOS imaging (Paris:EOSI) (Euronext, FR0011191766 – EOSI), the pioneer in 2D/3D orthopedic medical imaging, today announced the filing of its First-Half 2016 Financial Report.

The First-Half 2016 Financial Report is now available to the public, and has been registered with the Autorité des marchés financiers.

The Annual Financial Report is available at the registered office of the company (10 rue Mercœur - 75011 Paris) and on the EOS imaging’s website at www.eos-imaging.com in the section “Investors / Documentation / Financial Reports”.

For more information, please visit www.eos-imaging.com.

EOS imaging has been chosen to be included in the new EnterNext© PEA-PME 150 index, composed of 150 French companies and listed on Euronext and Alternext markets in Paris.

EOS imaging is listed on Compartment C of Euronext Paris
ISIN: FR0011191766 – Ticker: EOSI

About EOS imaging
EOS imaging designs, develops, and markets EOS®, an innovative medical imaging system dedicated to osteoarticular pathologies and orthopaedics, as well as associated solutions. The Company is authorized to market in 51 countries, including the United States (FDA), Japan, China, and the European Union (EC). The Group posted 2015 revenues of €21.8 million and employs 107 people including an R&D team of 39 engineers. The Group is based in Paris and has five subsidiaries in Besançon (France), Cambridge (Massachusetts), Montreal (Canada), Frankfurt (Germany) and Singapore.

View source version on businesswire.com: http://www.businesswire.com/news/home/20160921006078/en/

(c)Business Wire. All of the news releases contained herein are protected by copyright and other applicable laws, treaties and conventions. Information contained in the releases is furnished by Business Wire's members, who warrant that they are solely responsible for the content, accuracy and originality of the information contained therein. All reproduction, other than for an individual user's personal reference, is prohibited without prior written permission.